Industry

DUBLIN–(BUSINESS WIRE)–The “Global Medical Enzymes Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global medical enzymes market is estimated to progress with a CAGR of 6.78% during the forecast period 2022-2028. Companies Mentioned BASF SE Dupont Roche Holding AG Novozymes Dsm Sanofi Sa Codexis Advanced Enzymes Amano Enzyme Bbi Solutions Thermofisher Scientific Inc … [Read more…]

The €12M Series A round is led by Astanor Ventures; The funds raised will be invested in the next stages of development: bringing the casein production process to industrial scale, perfecting its processed products and initiating the regulatory process; Standing Ovation is participating in the creation of a sustainable agri-food industry by offering alternative proteins … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces that the first patient has been enrolled in its proof-of-concept clinical trial of SENS-401 (Arazasetron) in patients scheduled for cochlear … [Read more…]

– SparingVision is a French Biotech with the ambition of becoming a leader in genomics in ophthalmology. – Jeito Capital was a major investor in the Series A financing for SparingVision in 2020 and now co-leads the Series B financing to further support the Company’s growth trajectory, in accordance with its investment thesis: accelerating patient’s … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc. (NASDAQ: EWTX) today announced the pricing of its upsized underwritten public offering of 11,627,907 shares of its common stock at a price to the public of $10.32 per share. All of the shares are to be sold by Edgewise Therapeutics. In addition, Edgewise Therapeutics has granted the underwriters a 30-day … [Read more…]

An innovative and open solution bringing together multiple observation modes for future-proof endoscopic surgery TOKYO–(BUSINESS WIRE)–Olympus Corporation (“Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced the launch of VISERA ELITE III, its newest surgical visualization platform that addresses the needs of healthcare professionals (HCPs) for endoscopic procedures across multiple medical … [Read more…]

Following the first U.S. death officially attributed to monkeypox and reported in Los Angeles County, AHF now expands its call for public health officials to ramp up vaccine rollout and prevention messaging nationwide LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF), which has been sharply critical of Los Angeles County leadership in its handling of monkeypox, is … [Read more…]

SEATTLE–(BUSINESS WIRE)–Know Labs, Inc. (OTCQB: KNWN), an emerging leader of non-invasive medical diagnostic technology, today announced that, subject to official authorization and meeting all requirements (including the price requirement) at the time of listing, the Company has been approved to uplist to the NYSE American Exchange in conjunction with an underwritten public offering of the … [Read more…]

Investor Conference Call and KOL Forum From TCT 2022 Discussing DurAVR™ Clinical Data to be Hosted on Sept 19, 2022 at 8AM ET BRISBANE, Australia & EGAN, Minn.–(BUSINESS WIRE)–Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR™, the world’s only balloon-expandable, 3D single-piece native shaped aortic valve, announced today … [Read more…]

In less than two years, Gilead has more than doubled the cost of its HIV medication, Descovy, for the lifesaving 340B program from $445.11 in Q3, 2020 to $987.55 in Q2, 2022 AHF will host a protest Wednesday, Sept. 14th targeting Gilead Sciences—”Greediad”—and its investors over its AIDS drug pricing during the Baird Global Healthcare … [Read more…]